Chemed Co. (NYSE:CHE) Shares Bought by Inspire Investing LLC

Inspire Investing LLC grew its holdings in shares of Chemed Co. (NYSE:CHE) by 0.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,121 shares of the company’s stock after buying an additional 48 shares during the period. Inspire Investing LLC’s holdings in Chemed were worth $2,778,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in CHE. William Blair Investment Management LLC increased its holdings in shares of Chemed by 2.7% in the second quarter. William Blair Investment Management LLC now owns 475,372 shares of the company’s stock valued at $257,927,000 after buying an additional 12,705 shares in the last quarter. Impax Asset Management Group plc lifted its position in Chemed by 19.5% during the 2nd quarter. Impax Asset Management Group plc now owns 317,943 shares of the company’s stock worth $172,510,000 after acquiring an additional 51,974 shares during the last quarter. TD Asset Management Inc lifted its position in Chemed by 10.9% during the 2nd quarter. TD Asset Management Inc now owns 282,753 shares of the company’s stock worth $153,416,000 after acquiring an additional 27,800 shares during the last quarter. Boston Trust Walden Corp raised its position in shares of Chemed by 5.2% during the second quarter. Boston Trust Walden Corp now owns 221,440 shares of the company’s stock valued at $120,149,000 after buying an additional 11,036 shares during the last quarter. Finally, Epoch Investment Partners Inc. increased its stake in Chemed by 20.1% in the first quarter. Epoch Investment Partners Inc. now owns 182,776 shares of the company’s stock valued at $117,329,000 after acquiring an additional 30,614 shares during the period. Institutional investors own 95.85% of the company’s stock.

Chemed Trading Down 0.0 %

Shares of Chemed stock opened at $577.59 on Thursday. Chemed Co. has a 1-year low of $497.36 and a 1-year high of $654.62. The firm’s 50-day moving average price is $567.45 and its two-hundred day moving average price is $578.35. The stock has a market capitalization of $8.74 billion, a price-to-earnings ratio of 31.09, a P/E/G ratio of 2.31 and a beta of 0.44.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). The company had revenue of $595.88 million during the quarter, compared to the consensus estimate of $599.20 million. Chemed had a net margin of 12.88% and a return on equity of 29.21%. The company’s revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $4.71 earnings per share. As a group, equities research analysts predict that Chemed Co. will post 21.77 EPS for the current year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 12th were given a $0.50 dividend. This is a boost from Chemed’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a yield of 0.35%. The ex-dividend date of this dividend was Monday, August 12th. Chemed’s dividend payout ratio is 10.76%.

Insider Transactions at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Monday, August 5th. The shares were sold at an average price of $569.63, for a total value of $1,139,260.00. Following the completion of the transaction, the chief executive officer now owns 105,735 shares in the company, valued at $60,229,828.05. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director George J. Walsh III sold 200 shares of the company’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total transaction of $115,590.00. Following the completion of the sale, the director now owns 3,446 shares of the company’s stock, valued at approximately $1,991,615.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $569.63, for a total value of $1,139,260.00. Following the transaction, the chief executive officer now owns 105,735 shares of the company’s stock, valued at $60,229,828.05. The disclosure for this sale can be found here. Insiders sold a total of 6,744 shares of company stock worth $3,828,231 over the last three months. 3.32% of the stock is owned by company insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.